Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Ricciardelli
Letter: Effectiveness of Golimumab to Induce Remission in Outpatient Ulcerative Colitis in Italy
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Letter: How to Define Remission in Ulcerative Colitis - Histological Remission Should Be Considered
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: How to Define Remission in Ulcerative Colitis - Histological Remission Should Be Considered. Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Golimumab for the Treatment of Ulcerative Colitis
Expert Opinion on Biological Therapy
Drug Discovery
Clinical Biochemistry
Pharmacology
Maintaining Remission in Distal Ulcerative Colitis and Ulcerative Proctitis
Canadian Journal of Gastroenterology
Maintaining Remission From Ulcerative Colitis
Prescriber
Pharmacology
Letter: Dose Optimising Infliximab in Acute Severe Ulcerative Colitis
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Cost Per Response/Remission in Biologics Available in Italy for the Treatment of TNF-α Inhibitors-Naïve Patients With Ulcerative Colitis
Global and Regional Health Technology Assessment
Health Policy
Upregulation of GRAIL Is Associated With Remission of Ulcerative Colitis
American Journal of Physiology - Gastrointestinal and Liver Physiology
Hepatology
Physiology
Gastroenterology
Letter: Should We Intensify Infliximab in Acute Severe Ulcerative Colitis?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology